Share Price and Basic Stock Data
Last Updated: December 13, 2025, 1:30 am
| PEG Ratio | 3.35 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mastek Ltd operates in the IT consulting and software sector, showcasing a commendable growth trajectory. The company reported sales of ₹2,563 Cr for FY 2023, marking a rise from ₹2,184 Cr in FY 2022. This upward trend continued into FY 2024, where sales are projected to reach ₹3,055 Cr. The quarterly sales figures also reflect steady progress, with ₹766 Cr reported in September 2023, a significant increase from ₹709 Cr in March 2023. The sequential growth in sales indicates that Mastek is successfully capitalizing on emerging opportunities in the digital transformation space, which remains a high-demand area. However, the sales growth rate has shown signs of moderating, particularly with the latest quarter’s sales of ₹784 Cr for December 2023, suggesting that the company might face increased competition or market saturation. Overall, Mastek appears to be well-positioned but must navigate challenges to sustain its growth momentum.
Profitability and Efficiency Metrics
Profitability remains a key strength for Mastek, with the company reporting a net profit of ₹396 Cr for FY 2025, up from ₹310 Cr in FY 2023. The net profit margin stood at 10.88%, reflecting effective cost management despite rising expenses that reached ₹2,909 Cr in FY 2025. The operating profit margin (OPM) has shown some fluctuation, declining to 16% in FY 2025 from a peak of 21% in FY 2022. This decline may indicate pressures from rising operational costs and competitive pricing strategies. The return on equity (ROE) was recorded at 16.1%, suggesting a robust capacity to generate earnings from shareholder equity, while the return on capital employed (ROCE) at 17.3% underscores effective utilization of capital. However, the cash conversion cycle (CCC) at 78 days raises a flag, as it indicates that Mastek’s efficiency in managing receivables and payables could be improved, potentially affecting liquidity.
Balance Sheet Strength and Financial Ratios
Mastek’s balance sheet exhibits a solid foundation, with total assets amounting to ₹3,848 Cr as of March 2025, against liabilities of ₹3,848 Cr. The company’s borrowings have increased to ₹544 Cr, but the debt-to-equity ratio remains comfortable at 0.22, indicating prudent leverage. The interest coverage ratio of 13.52x suggests that Mastek can easily meet its interest obligations, a reassuring sign for investors. Moreover, the book value per share has increased to ₹795.84, reflecting the company’s growing net worth. However, the price-to-book value ratio of 2.74x could be viewed as somewhat stretched, given the market’s expectations for growth. Investors should note that while the financial ratios appear stable, any significant increase in debt or a downturn in profitability could impact the balance sheet’s strength.
Shareholding Pattern and Investor Confidence
Mastek’s shareholding pattern reveals a diverse ownership structure, with public shareholders holding 41.45% of the stake, while promoters own 35.79%. Notably, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have shown increasing confidence, holding 11.24% and 11.52% of shares, respectively. This gradual increase in institutional ownership may reflect positive sentiment towards Mastek’s growth prospects. However, the declining promoter stake—from 37.27% in December 2022 to 35.79% in September 2025—could raise questions about insider confidence in the company’s future. The number of shareholders has also seen fluctuations, with a peak of 1,07,613 in December 2022, which declined to 1,00,780 by September 2025. This drop could indicate a level of uncertainty among retail investors, suggesting that Mastek needs to enhance communication and transparency to retain investor trust.
Outlook, Risks, and Final Insight
Looking ahead, Mastek’s growth trajectory appears promising, but several risks could pose challenges. The IT consulting sector is highly competitive, with pressures to innovate and maintain service quality. Additionally, the company’s dependency on key clients for revenue could expose it to fluctuations in demand. The rising operational costs reflected in the declining OPM may also hinder profitability if not managed effectively. Furthermore, macroeconomic factors, including global economic conditions and currency fluctuations, could impact Mastek’s international operations. Investors should consider these aspects when evaluating Mastek’s potential. While the fundamentals are strong, the company must navigate these risks to sustain its growth, making it crucial for retail investors to stay informed and engaged with Mastek’s performance and strategic decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 49.2 Cr. | 15.6 | 15.6/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 151 Cr. | 140 | 194/99.8 | 23.1 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 25.6 Cr. | 200 | 310/140 | 18.3 | 26.7 | 0.50 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.28 Cr. | 1.08 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,491.18 Cr | 558.12 | 86.50 | 123.78 | 0.54% | 14.89% | 20.93% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 570 | 625 | 659 | 709 | 725 | 766 | 784 | 780 | 813 | 867 | 870 | 905 | 915 |
| Expenses | 461 | 518 | 545 | 584 | 598 | 642 | 651 | 655 | 689 | 724 | 729 | 767 | 777 |
| Operating Profit | 109 | 107 | 114 | 126 | 127 | 123 | 134 | 125 | 124 | 143 | 141 | 139 | 137 |
| OPM % | 19% | 17% | 17% | 18% | 18% | 16% | 17% | 16% | 15% | 16% | 16% | 15% | 15% |
| Other Income | 26 | 32 | 6 | -0 | 2 | 1 | 3 | 5 | 4 | 17 | 13 | -5 | 11 |
| Interest | 2 | 5 | 8 | 9 | 9 | 13 | 13 | 9 | 9 | 11 | 12 | 10 | 9 |
| Depreciation | 11 | 17 | 20 | 20 | 20 | 21 | 22 | 27 | 20 | 20 | 17 | 19 | 18 |
| Profit before tax | 122 | 117 | 92 | 96 | 100 | 90 | 102 | 94 | 99 | 129 | 126 | 106 | 121 |
| Tax % | 31% | 27% | 27% | 25% | 27% | 28% | 24% | -1% | 28% | 0% | 25% | 23% | 24% |
| Net Profit | 84 | 86 | 67 | 73 | 74 | 65 | 78 | 94 | 72 | 129 | 95 | 81 | 92 |
| EPS in Rs | 25.68 | 26.30 | 21.33 | 23.77 | 22.91 | 20.50 | 24.56 | 29.85 | 23.18 | 41.68 | 30.67 | 26.20 | 29.75 |
Last Updated: August 1, 2025, 5:20 pm
Below is a detailed analysis of the quarterly data for Mastek Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 915.00 Cr.. The value appears strong and on an upward trend. It has increased from 905.00 Cr. (Mar 2025) to 915.00 Cr., marking an increase of 10.00 Cr..
- For Expenses, as of Jun 2025, the value is 777.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 767.00 Cr. (Mar 2025) to 777.00 Cr., marking an increase of 10.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 139.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 2.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -5.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 16.00 Cr..
- For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 121.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 15.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 24.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 11.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 29.75. The value appears strong and on an upward trend. It has increased from 26.20 (Mar 2025) to 29.75, marking an increase of 3.55.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:23 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 923 | 1,013 | 527 | 560 | 817 | 1,033 | 1,071 | 1,722 | 2,184 | 2,563 | 3,055 | 3,455 | 3,557 |
| Expenses | 833 | 965 | 509 | 515 | 718 | 902 | 916 | 1,357 | 1,721 | 2,108 | 2,546 | 2,909 | 2,997 |
| Operating Profit | 90 | 47 | 18 | 45 | 100 | 132 | 156 | 364 | 463 | 456 | 509 | 546 | 560 |
| OPM % | 10% | 5% | 3% | 8% | 12% | 13% | 15% | 21% | 21% | 18% | 17% | 16% | 16% |
| Other Income | 11 | 14 | 15 | 12 | 21 | 25 | 17 | 28 | 36 | 64 | 12 | 30 | 36 |
| Interest | 1 | 1 | 0 | 4 | 6 | 6 | 4 | 8 | 8 | 25 | 44 | 42 | 41 |
| Depreciation | 33 | 37 | 16 | 15 | 19 | 17 | 25 | 45 | 43 | 67 | 90 | 75 | 73 |
| Profit before tax | 68 | 22 | 16 | 39 | 96 | 133 | 144 | 339 | 448 | 427 | 386 | 459 | 481 |
| Tax % | 24% | 20% | 17% | 17% | 27% | 24% | 21% | 26% | 26% | 27% | 19% | 18% | |
| Net Profit | 52 | 18 | 14 | 32 | 70 | 101 | 114 | 252 | 333 | 310 | 311 | 376 | 396 |
| EPS in Rs | 23.37 | 7.86 | 5.97 | 13.86 | 29.53 | 42.33 | 44.82 | 82.97 | 98.32 | 95.99 | 97.36 | 121.50 | 128.30 |
| Dividend Payout % | 19% | 32% | 42% | 25% | 20% | 20% | 18% | 17% | 19% | 20% | 20% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -65.38% | -22.22% | 128.57% | 118.75% | 44.29% | 12.87% | 121.05% | 32.14% | -6.91% | 0.32% | 20.90% |
| Change in YoY Net Profit Growth (%) | 0.00% | 43.16% | 150.79% | -9.82% | -74.46% | -31.41% | 108.18% | -88.91% | -39.05% | 7.23% | 20.58% |
Mastek Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 26% |
| 3 Years: | 17% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 25% |
| 3 Years: | 9% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 29% |
| 3 Years: | 11% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 549 | 585 | 308 | 457 | 537 | 704 | 778 | 846 | 1,056 | 1,668 | 2,072 | 2,447 | 2,661 |
| Borrowings | 2 | 29 | 0 | 66 | 70 | 70 | 335 | 273 | 203 | 404 | 519 | 583 | 544 |
| Other Liabilities | 192 | 207 | 108 | 170 | 202 | 179 | 763 | 1,146 | 1,193 | 1,024 | 1,045 | 803 | 813 |
| Total Liabilities | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 | 4,034 |
| Fixed Assets | 261 | 279 | 66 | 180 | 179 | 167 | 857 | 807 | 841 | 1,740 | 1,950 | 1,818 | 1,846 |
| CWIP | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 4 | 7 | 1 | 2 | 2 |
| Investments | 84 | 54 | 50 | 274 | 284 | 396 | 276 | 234 | 26 | 69 | 94 | 178 | 188 |
| Other Assets | 409 | 498 | 312 | 251 | 356 | 401 | 754 | 1,235 | 1,596 | 1,296 | 1,607 | 1,851 | 1,998 |
| Total Assets | 754 | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 | 4,034 |
Below is a detailed analysis of the balance sheet data for Mastek Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,661.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,447.00 Cr. (Mar 2025) to 2,661.00 Cr., marking an increase of 214.00 Cr..
- For Borrowings, as of Sep 2025, the value is 544.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 583.00 Cr. (Mar 2025) to 544.00 Cr., marking a decrease of 39.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 813.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 803.00 Cr. (Mar 2025) to 813.00 Cr., marking an increase of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,034.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,848.00 Cr. (Mar 2025) to 4,034.00 Cr., marking an increase of 186.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,846.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,818.00 Cr. (Mar 2025) to 1,846.00 Cr., marking an increase of 28.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Investments, as of Sep 2025, the value is 188.00 Cr.. The value appears strong and on an upward trend. It has increased from 178.00 Cr. (Mar 2025) to 188.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,998.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,851.00 Cr. (Mar 2025) to 1,998.00 Cr., marking an increase of 147.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,034.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,848.00 Cr. (Mar 2025) to 4,034.00 Cr., marking an increase of 186.00 Cr..
Notably, the Reserves (2,661.00 Cr.) exceed the Borrowings (544.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 88.00 | 18.00 | 18.00 | -21.00 | 30.00 | 62.00 | -179.00 | 91.00 | 260.00 | 52.00 | -10.00 | -37.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 46 | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 |
| Working Capital Days | 26 | 25 | 38 | 29 | 15 | 38 | 4 | -35 | -20 | 34 | -1 | 28 |
| ROCE % | 12% | 5% | 3% | 10% | 17% | 19% | 16% | 26% | 32% | 23% | 18% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Digital India Fund | 680,894 | 1.24 | 145.68 | 155,070 | 2025-12-08 01:19:52 | 339.09% |
| Bandhan Small Cap Fund | 322,058 | 0.4 | 68.91 | N/A | N/A | N/A |
| ICICI Prudential Technology Fund | 232,734 | 0.33 | 49.8 | 250,560 | 2025-12-08 01:19:52 | -7.11% |
| Bandhan Large & Mid Cap Fund | 206,982 | 0.38 | 44.29 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 84,674 | 0.11 | 18.12 | N/A | N/A | N/A |
| WhiteOak Capital Flexi Cap Fund | 69,640 | 0.23 | 14.9 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Pure Equity | 26,288 | 0.37 | 5.62 | N/A | N/A | N/A |
| LIC MF Small Cap Fund | 24,509 | 0.81 | 5.24 | N/A | N/A | N/A |
| LIC MF Value Fund | 12,360 | 1.25 | 2.64 | N/A | N/A | N/A |
| WhiteOak Capital ELSS Tax Saver Fund | 4,742 | 0.23 | 1.01 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 121.78 | 98.01 | 97.23 | 106.52 | 84.92 |
| Diluted EPS (Rs.) | 120.65 | 97.25 | 95.53 | 106.52 | 81.88 |
| Cash EPS (Rs.) | 145.78 | 129.99 | 123.74 | 125.35 | 117.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 795.84 | 676.85 | 581.42 | 406.96 | 336.32 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 795.84 | 676.85 | 581.42 | 406.96 | 336.32 |
| Revenue From Operations / Share (Rs.) | 1116.75 | 990.53 | 839.90 | 727.46 | 682.19 |
| PBDIT / Share (Rs.) | 183.82 | 170.13 | 161.91 | 166.09 | 155.46 |
| PBIT / Share (Rs.) | 159.54 | 140.98 | 139.83 | 151.81 | 137.65 |
| PBT / Share (Rs.) | 148.40 | 125.22 | 140.03 | 149.25 | 134.44 |
| Net Profit / Share (Rs.) | 121.50 | 100.83 | 101.66 | 111.07 | 99.74 |
| NP After MI And SOA / Share (Rs.) | 121.50 | 97.37 | 96.01 | 98.31 | 82.94 |
| PBDIT Margin (%) | 16.45 | 17.17 | 19.27 | 22.83 | 22.78 |
| PBIT Margin (%) | 14.28 | 14.23 | 16.64 | 20.86 | 20.17 |
| PBT Margin (%) | 13.28 | 12.64 | 16.67 | 20.51 | 19.70 |
| Net Profit Margin (%) | 10.88 | 10.17 | 12.10 | 15.26 | 14.62 |
| NP After MI And SOA Margin (%) | 10.88 | 9.83 | 11.43 | 13.51 | 12.15 |
| Return on Networth / Equity (%) | 15.26 | 14.38 | 17.40 | 27.54 | 17.93 |
| Return on Capital Employeed (%) | 16.88 | 16.75 | 17.74 | 27.85 | 22.21 |
| Return On Assets (%) | 9.73 | 8.14 | 9.32 | 11.86 | 9.11 |
| Long Term Debt / Equity (X) | 0.15 | 0.15 | 0.15 | 0.11 | 0.16 |
| Total Debt / Equity (X) | 0.22 | 0.23 | 0.22 | 0.17 | 0.16 |
| Asset Turnover Ratio (%) | 0.91 | 0.89 | 0.18 | 0.17 | 0.16 |
| Current Ratio (X) | 1.95 | 1.42 | 1.69 | 1.78 | 1.87 |
| Quick Ratio (X) | 1.95 | 1.42 | 1.69 | 1.78 | 1.87 |
| Dividend Payout Ratio (NP) (%) | 15.60 | 19.39 | 19.59 | 16.10 | 6.50 |
| Dividend Payout Ratio (CP) (%) | 13.00 | 14.92 | 15.93 | 14.06 | 5.35 |
| Earning Retention Ratio (%) | 84.40 | 80.61 | 80.41 | 83.90 | 93.50 |
| Cash Earning Retention Ratio (%) | 87.00 | 85.08 | 84.07 | 85.94 | 94.65 |
| Interest Coverage Ratio (X) | 13.52 | 11.80 | 19.99 | 64.92 | 48.44 |
| Interest Coverage Ratio (Post Tax) (X) | 9.76 | 8.09 | 12.53 | 44.41 | 32.08 |
| Enterprise Value (Cr.) | 6839.86 | 7924.50 | 4956.73 | 9576.73 | 2360.43 |
| EV / Net Operating Revenue (X) | 1.98 | 2.59 | 1.93 | 4.39 | 1.37 |
| EV / EBITDA (X) | 12.03 | 15.10 | 10.03 | 19.21 | 6.02 |
| MarketCap / Net Operating Revenue (X) | 1.95 | 2.56 | 1.83 | 4.56 | 1.79 |
| Retention Ratios (%) | 84.39 | 80.60 | 80.40 | 83.89 | 93.49 |
| Price / BV (X) | 2.74 | 3.75 | 2.79 | 9.30 | 2.64 |
| Price / Net Operating Revenue (X) | 1.95 | 2.56 | 1.83 | 4.56 | 1.79 |
| EarningsYield | 0.05 | 0.03 | 0.06 | 0.02 | 0.06 |
After reviewing the key financial ratios for Mastek Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 121.78. This value is within the healthy range. It has increased from 98.01 (Mar 24) to 121.78, marking an increase of 23.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 120.65. This value is within the healthy range. It has increased from 97.25 (Mar 24) to 120.65, marking an increase of 23.40.
- For Cash EPS (Rs.), as of Mar 25, the value is 145.78. This value is within the healthy range. It has increased from 129.99 (Mar 24) to 145.78, marking an increase of 15.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 795.84. It has increased from 676.85 (Mar 24) to 795.84, marking an increase of 118.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 795.84. It has increased from 676.85 (Mar 24) to 795.84, marking an increase of 118.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,116.75. It has increased from 990.53 (Mar 24) to 1,116.75, marking an increase of 126.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 183.82. This value is within the healthy range. It has increased from 170.13 (Mar 24) to 183.82, marking an increase of 13.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 159.54. This value is within the healthy range. It has increased from 140.98 (Mar 24) to 159.54, marking an increase of 18.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 148.40. This value is within the healthy range. It has increased from 125.22 (Mar 24) to 148.40, marking an increase of 23.18.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 121.50. This value is within the healthy range. It has increased from 100.83 (Mar 24) to 121.50, marking an increase of 20.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 121.50. This value is within the healthy range. It has increased from 97.37 (Mar 24) to 121.50, marking an increase of 24.13.
- For PBDIT Margin (%), as of Mar 25, the value is 16.45. This value is within the healthy range. It has decreased from 17.17 (Mar 24) to 16.45, marking a decrease of 0.72.
- For PBIT Margin (%), as of Mar 25, the value is 14.28. This value is within the healthy range. It has increased from 14.23 (Mar 24) to 14.28, marking an increase of 0.05.
- For PBT Margin (%), as of Mar 25, the value is 13.28. This value is within the healthy range. It has increased from 12.64 (Mar 24) to 13.28, marking an increase of 0.64.
- For Net Profit Margin (%), as of Mar 25, the value is 10.88. This value exceeds the healthy maximum of 10. It has increased from 10.17 (Mar 24) to 10.88, marking an increase of 0.71.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.88. This value is within the healthy range. It has increased from 9.83 (Mar 24) to 10.88, marking an increase of 1.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.26. This value is within the healthy range. It has increased from 14.38 (Mar 24) to 15.26, marking an increase of 0.88.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.88. This value is within the healthy range. It has increased from 16.75 (Mar 24) to 16.88, marking an increase of 0.13.
- For Return On Assets (%), as of Mar 25, the value is 9.73. This value is within the healthy range. It has increased from 8.14 (Mar 24) to 9.73, marking an increase of 1.59.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.15.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.22, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has increased from 0.89 (Mar 24) to 0.91, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.95, marking an increase of 0.53.
- For Quick Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.95, marking an increase of 0.53.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.60. This value is below the healthy minimum of 20. It has decreased from 19.39 (Mar 24) to 15.60, marking a decrease of 3.79.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 20. It has decreased from 14.92 (Mar 24) to 13.00, marking a decrease of 1.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 84.40. This value exceeds the healthy maximum of 70. It has increased from 80.61 (Mar 24) to 84.40, marking an increase of 3.79.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.00. This value exceeds the healthy maximum of 70. It has increased from 85.08 (Mar 24) to 87.00, marking an increase of 1.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 11.80 (Mar 24) to 13.52, marking an increase of 1.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.76. This value is within the healthy range. It has increased from 8.09 (Mar 24) to 9.76, marking an increase of 1.67.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6,839.86. It has decreased from 7,924.50 (Mar 24) to 6,839.86, marking a decrease of 1,084.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 2.59 (Mar 24) to 1.98, marking a decrease of 0.61.
- For EV / EBITDA (X), as of Mar 25, the value is 12.03. This value is within the healthy range. It has decreased from 15.10 (Mar 24) to 12.03, marking a decrease of 3.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.56 (Mar 24) to 1.95, marking a decrease of 0.61.
- For Retention Ratios (%), as of Mar 25, the value is 84.39. This value exceeds the healthy maximum of 70. It has increased from 80.60 (Mar 24) to 84.39, marking an increase of 3.79.
- For Price / BV (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has decreased from 3.75 (Mar 24) to 2.74, marking a decrease of 1.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.56 (Mar 24) to 1.95, marking a decrease of 0.61.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mastek Ltd:
- Net Profit Margin: 10.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.88% (Industry Average ROCE: 14.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.26% (Industry Average ROE: 20.93%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.76
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.95
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.3 (Industry average Stock P/E: 86.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 804/805, President House, Opp. C N Vidyalaya, Ahmedabad Gujarat 380006 | investor_grievances@mastek.com http://www.mastek.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashank Desai | Chairman, Non Ind & Non Exe Director |
| Mr. Umang Nahata | WholeTime Director & CEO |
| Mr. Ketan Mehta | Non Exe.Non Ind.Director |
| Mr. Suresh Vaswani | Ind. Non-Executive Director |
| Mr. Rajeev Kumar Grover | Ind. Non-Executive Director |
| Ms. Marilyn Jones | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mastek Ltd?
Mastek Ltd's intrinsic value (as of 13 December 2025) is 2058.07 which is 5.25% lower the current market price of 2,172.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,732 Cr. market cap, FY2025-2026 high/low of 3,350/1,883, reserves of ₹2,661 Cr, and liabilities of 4,034 Cr.
What is the Market Cap of Mastek Ltd?
The Market Cap of Mastek Ltd is 6,732 Cr..
What is the current Stock Price of Mastek Ltd as on 13 December 2025?
The current stock price of Mastek Ltd as on 13 December 2025 is 2,172.
What is the High / Low of Mastek Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mastek Ltd stocks is 3,350/1,883.
What is the Stock P/E of Mastek Ltd?
The Stock P/E of Mastek Ltd is 18.3.
What is the Book Value of Mastek Ltd?
The Book Value of Mastek Ltd is 864.
What is the Dividend Yield of Mastek Ltd?
The Dividend Yield of Mastek Ltd is 1.06 %.
What is the ROCE of Mastek Ltd?
The ROCE of Mastek Ltd is 17.3 %.
What is the ROE of Mastek Ltd?
The ROE of Mastek Ltd is 16.1 %.
What is the Face Value of Mastek Ltd?
The Face Value of Mastek Ltd is 5.00.